Trending Topic

Acute myeloid leukaemia
3 mins

Trending Topic

Developed by Touch
Mark CompleteCompleted
BookmarkBookmarked

“We are facing an exciting era of fast-paced drug development in acute myeloid leukaemia” writes Gianfranco Bittar and colleagues at Baylor College of Medicine, Houston, TX, USA, in a review published in touchREVIEWS in Oncology & Haematology. In 2020, there were an estimated 21,450 new patients with acute myeloid leukaemia (AML) and 11,180 AML-related deaths […]

7 mins

María-Victoria Mateos: Bispecific monoclonal antibodies for patients with refractory/relapsed multiple myeloma

María-Victoria Mateos
Share
Facebook
X (formerly Twitter)
LinkedIn
Via Email
Mark CompleteCompleted
BookmarkBookmarked
Copy LinkLink Copied
Published Online: Feb 10th 2023

We were delighted to speak with María-Victoria Mateos (University of Salamanca, Salamanca, Spain) about the recent updates in bispecific monoclonal antibodies for patients with refractory/relapsed multiple myeloma.

Disclosures: María-Victoria Mateos discloses the following –  Advisory Board or panel fees from Abbvie, Adaptive, Amgen, Celgene, GlaxoSmithKline, Genentech, Janssen, Oncopeptides, Pfizer, Regeneron, Roche, Sanofi and Takeda. Speaker’s Bureau fees from Amgen, Celgene, GlaxoSmithKline, Janssen and Takeda.

Support: Interview and filming supported by Touch Medical Media. Interview conducted by Nicola Cartridge.

View more multiple myeloma content:

  • Dr María-Victoria Mateos (University of Salamanca, Salamanca, Spain) shares her thoughts on the current challenges in CAR-T cell therapy and the strategies being investigated to address them. Watch here on touchHAEMATOLOGY
  • Dr Shaji Kumar (Mayo Clinic, MN, USA) discusses the results of some key clinical trials presented at ASH 2022 in the field of older, frail transplant ineligible patients with multiple myeloma. Watch here
  • Dr Joseph Franz and Dr Sagar Lonial discuss the recent ATLAS study (ClinicalTrials.gov Identifier: NCT02659293) and optimal post-ASCT management in patients with multiple myeloma. Read here
Share
Facebook
X (formerly Twitter)
LinkedIn
Via Email
Mark CompleteCompleted
BookmarkBookmarked
Copy LinkLink Copied

This Functionality is for
Members Only

Explore the latest in medical education and stay current in your field. Create a free account to track your learning.

Close Popup